B-Cell Maturation Antigen (CD269) as a Predictor for Response to Treatment in Multiple Myeloma Patients.
Abdullah, R., Embaby, A., Hamed, G. (2025). B-Cell Maturation Antigen (CD269) as a Predictor for Response to Treatment in Multiple Myeloma Patients.. EKB Journal Management System, 31(3), 1067-1075. doi: 10.21608/zumj.2025.347374.3761
Rania M Abdullah; Ahmed Embaby; Gehad Hamed. "B-Cell Maturation Antigen (CD269) as a Predictor for Response to Treatment in Multiple Myeloma Patients.". EKB Journal Management System, 31, 3, 2025, 1067-1075. doi: 10.21608/zumj.2025.347374.3761
Abdullah, R., Embaby, A., Hamed, G. (2025). 'B-Cell Maturation Antigen (CD269) as a Predictor for Response to Treatment in Multiple Myeloma Patients.', EKB Journal Management System, 31(3), pp. 1067-1075. doi: 10.21608/zumj.2025.347374.3761
Abdullah, R., Embaby, A., Hamed, G. B-Cell Maturation Antigen (CD269) as a Predictor for Response to Treatment in Multiple Myeloma Patients.. EKB Journal Management System, 2025; 31(3): 1067-1075. doi: 10.21608/zumj.2025.347374.3761